Multimodal therapy successfully treats methemoglobinemia caused by emamectin benzoate and indoxacarb poisoning: a case report.

IF 2.4 3区医学 Q2 PATHOLOGY

Diagnostic Pathology Pub Date : 2025-04-05 DOI:10.1186/s13000-025-01634-1

Qun Zhang, Yun-Yang Luan, Fei-Fei Sun, Yong-Qiang Chen, Shuang-de Wang, Guang-Wen Hu

引用次数: 0

Abstract

Poisoning from emamectin benzoate combined with indoxacarb can cause neurological symptoms and methemoglobinemia, which may present clinically as confusion, cyanosis, dyspnea, and limb convulsions. In such cases, naloxone can be used to alleviate neurological symptoms, while high-dose vitamin C and low-concentration methylene blue can reduce methemoglobin (MetHb) to improve hypoxic symptoms. Hemoperfusion and continuous renal replacement therapy (CRRT) can rapidly remove exogenous and endogenous toxins from the blood, effectively protecting against organ damage to the heart, liver, and kidneys caused by emamectin benzoate poisoning.

查看原文本刊更多论文

多模式治疗成功治疗由苯甲酸埃维菌素和吲哚虫威中毒引起的高铁血红蛋白血症1例。

苯甲酸埃维菌素联合吲哚虫威中毒可引起神经系统症状和高铁血红蛋白血症，在临床上可表现为精神错乱、发绀、呼吸困难和肢体抽搐。在这种情况下，纳洛酮可用于缓解神经系统症状，而大剂量维生素C和低浓度亚甲基蓝可减少高铁血红蛋白（MetHb），以改善缺氧症状。血液灌流和持续肾替代疗法（CRRT）可以快速清除血液中的外源性和内源性毒素，有效地保护心脏、肝脏和肾脏免受苯甲酸埃维菌素中毒引起的器官损害。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diagnostic Pathology 医学-病理学

CiteScore

4.60

自引率

0.00%

发文量

审稿时长

1 months

期刊介绍： Diagnostic Pathology is an open access, peer-reviewed, online journal that considers research in surgical and clinical pathology, immunology, and biology, with a special focus on cutting-edge approaches in diagnostic pathology and tissue-based therapy. The journal covers all aspects of surgical pathology, including classic diagnostic pathology, prognosis-related diagnosis (tumor stages, prognosis markers, such as MIB-percentage, hormone receptors, etc.), and therapy-related findings. The journal also focuses on the technological aspects of pathology, including molecular biology techniques, morphometry aspects (stereology, DNA analysis, syntactic structure analysis), communication aspects (telecommunication, virtual microscopy, virtual pathology institutions, etc.), and electronic education and quality assurance (for example interactive publication, on-line references with automated updating, etc.).